ECM
Endurant Capital Management Portfolio holdings
AUM
$17.4M
1-Year Return
4.95%
This Quarter Return
-4.03%
1 Year Return
+4.95%
3 Year Return
+16.8%
5 Year Return
+58.39%
10 Year Return
–
AUM
$307M
AUM Growth
+$44.9M
(+17%)
Cap. Flow
+$58.1M
Cap. Flow
% of AUM
18.91%
Top 10 Holdings %
Top 10 Hldgs %
56.38%
Holding
70
New
21
Increased
13
Reduced
13
Closed
19
Top Buys
| 1 |
Takeda Pharmaceutical
TAK
|
$14.3M |
| 2 |
Labcorp
LH
|
$12.8M |
| 3 |
Eli Lilly
LLY
|
$12.4M |
| 4 |
Bristol-Myers Squibb
BMY
|
$11.3M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
$10.1M |
Top Sells
| 1 |
Boston Scientific
BSX
|
$15.6M |
| 2 |
Hologic
HOLX
|
$8.85M |
| 3 |
Avantor
AVTR
|
$7.35M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$5.82M |
| 5 |
Centene
CNC
|
$5.78M |
Sector Composition
| 1 | Healthcare | 77.14% |
| 2 | Real Estate | 4.13% |
